venBio Partners’s Yarrow Bioscience YARW Stock Holding History

venBio Partners’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-406	Closed	-$3.92M	–	5
2020 Q1	$3.92M	Hold	406	–	–	3.34%	5
2019 Q4	$6.78M	Hold	406	–	–	2.91%	5
2019 Q3	$6.55M	Hold	406	–	–	3.11%	5
2019 Q2	$8.76M	Hold	406	–	–	3.89%	5
2019 Q1	$11.5M	Hold	406	–	–	9.29%	3
2018 Q4	$6.02M	Hold	406	–	–	15.82%	3
2018 Q3	$14.4M	Hold	406	–	–	25.18%	2
2018 Q2	$11.9M	Hold	406	–	–	12.24%	3
2018 Q1	$54.9M	Buy	+406	New	+$49.4M	33.85%	2

Other funds holding YARW

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

venBio Partners's YARW Position: Q2 2020 in Review

venBio Partners sold out of Yarrow Bioscience (YARW) in Q2 2020, closing a stake of 406 shares — an estimated $3.92M sold.

venBio Partners first reported a position in YARW in Q1 2018 and held it in 9 quarters. The position peaked at $54.9M in Q1 2018. 98 funds tracked by Wall St. Rank hold YARW as of Q2 2020.

venBio Partners reported no remaining Yarrow Bioscience position as of Q2 2020 after selling out during the quarter.
venBio Partners sold 406 Yarrow Bioscience shares in Q2 2020, an estimated $3.92M.
venBio Partners first reported a position in Yarrow Bioscience in Q1 2018 and held it in 9 quarters.
venBio Partners's Yarrow Bioscience position peaked at $54.9M in Q1 2018.
98 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2020.

Based on venBio Partners's 13F filing for Q2 2020, filed 14 Aug 2020.